Skip to content

Examination of the effect of continuous intake of test foods on immune function.

Examination of the effect of continuous intake of test foods on immune function. - Examination of the effect of continuous intake of test foods on immune function.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042449
Enrollment
40
Registered
2020-11-23
Start date
2020-11-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sponsors

IMEQRD Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 40 to under 70 at the time of informed consent. 2. Male and female 3. Those who are susceptible to upper respiratory tract infections in winter every year. 4. Those who can input electronic diary with smartphone / PC 5. Those who can obtain written consent

Exclusion criteria

Exclusion criteria: 1.Those who are currently under continuous treatment with drugs. (Abortive use is acceptable.) 2. Those who are on a diet or exercise therapy under the supervision of a doctor. 3. Those who have a current or history of serious illness. 4. Those with atopic dermatitis, allergic rhinitis (seasonal / perennial), bronchial asthma, chronic bronchitis 5. Those who are currently using quasi-drugs, foods for specified health uses, health foods and supplements. Those who can quit during the test period after obtaining consent are allowed to participate. 6. Those who regularly intake foods containing lactic acid bacteria or bifidobacterium. 7. Those who have been vaccinated with influenza vaccine within 1 month before the pre-intake test, or who will be vaccinated during the test period 8. Those who have a past and current medical history of drug or food allergy. 9. Those who work in shifts, such as those who work night shifts 10. Those who consume alcohol excessively (alcohol equivalent 60g or more / day) 11. Those who have excessive smoking habits (21 or more cigarettes / day) 12. Those who are planning to travel abroad during the test period 13. Those who wish to become pregnant, breastfeeding, or during the test period 14. Those who have participated in other clinical trials within one month before obtaining consent, or those who plan to participate during the test period 15. Those who are judged by the investigator or coordinator to be unsuitable for participating in this study

Design outcomes

Primary

MeasureTime frame
Inflammatory markers, body temperature measurement, questionnaire

Countries

Japan

Contacts

Public ContactHirokuni Kayama

IMEQRD Co., Ltd Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026